Journal of Thyroid Disorders & Therapy

Journal of Thyroid Disorders & Therapy
Open Access

ISSN: 2167-7948

+44 1300 500008

Shahid SB

Shahid SB
College of Pharmacy,
Slovak republic

Biography
Dr. Shahid S. B. is a distinguished pharmacologist affiliated with the Department of Pharmacology at the College of Pharmacy, King Khalid University in the Kingdom of Saudi Arabia. His research primarily focuses on thyroid disorders, particularly subclinical hypothyroidism and its associated health implications. In 2018, Dr. Shahid authored a comprehensive review titled "Subclinical Hypothyroidism and its Associated Disorders," published in the Journal of Clinical and Cellular Immunology. This work delves into the early, mild form of hypothyroidism, where the body doesn't produce sufficient thyroid hormones, and explores its potential links to various health conditions. The review emphasizes the importance of early detection and management to prevent progression to overt hypothyroidism and mitigate associated health risks. Dr. Shahid's contributions to the field of pharmacology, particularly in understanding thyroid function and its systemic effects, have been instrumental in advancing medical knowledge and improving patient care.
Publications
  • Review Article
    Subclinical Hypothyroidism and its Associated Disorders
    Author(s): Shahid SBShahid SB

    Subclinical hypothyroidism is an early, mild form of hypothyroidism, a condition in which the body doesn’t produce enough thyroid hormones. These hormones are required for normal heart, brain, and metabolic functions. Subclinical hypothyroidism is diagnosed with a blood test. Normal reference range for TSH is considered to be 4.5 mIU/L or 5.0 mIU/L slightly elevated TSH levels along with normal range T3 and T4 hormones are considered to be presentation of SCH. Whether to treat these patients with thyroxine is still a question of debate. SCH is associated with various signs and symptoms. It is highly recommended to use thyroxine in SCH pregnant patients as there are convincing reports of danger to mother and fetus. Infertile SCH females have also shown to benefit with thyroxine therapy. SCH has also been linked with effects on cardiovascular disorders, lipid abnormalities, DVT, w.. View More»

    Abstract PDF

Relevant Topics

Top